Cogent Biosciences (NASDAQ:COGT) Downgraded by Zacks Investment Research to Sell

Cogent Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Cogent Biosciences Downgraded by Zacks Investment Research on 10/18/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Cogent Biosciences (NASDAQ:COGT) Downgraded by Zacks Investment Research to Sell